BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29255356)

  • 1. Predictive value of ADAMTS-13 on concealed chronic renal failure in COPD patients.
    Zeng M; Chen Q; Liang W; He W; Zheng H; Huang C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3495-3501. PubMed ID: 29255356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal failure: a neglected comorbidity of COPD.
    Incalzi RA; Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V;
    Chest; 2010 Apr; 137(4):831-7. PubMed ID: 19903974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
    Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein levels in stable COPD patients: a case-control study.
    Silva DR; Gazzana MB; Knorst MM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
    Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
    Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Renal Impairment an Anticipated COPD Comorbidity?
    AbdelHalim HA; AboElNaga HH
    Respir Care; 2016 Sep; 61(9):1201-6. PubMed ID: 27118874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Sarcopenia and Chronic Renal Failure (Overt and Concealed) in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Cross-Sectional Study.
    M Y; Dave AK; Patel SS; Parbat R; Shah V; Gandhi R
    Cureus; 2023 Oct; 15(10):e46870. PubMed ID: 37954830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
    Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
    Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
    Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Utility of Biomarkers in COPD.
    Ambade VN; Sontakke AN; Barthwal MS; Tyagi R; Basannar DR
    Respir Care; 2015 Dec; 60(12):1729-42. PubMed ID: 26106205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
    Kanda E; Usui T; Kashihara N; Iseki C; Iseki K; Nangaku M
    Clin Exp Nephrol; 2018 Apr; 22(2):318-327. PubMed ID: 28884361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism.
    Kostrubiec M; Łabyk A; Pedowska-Włoszek J; Dzikowska-Diduch O; Wojciechowski A; Garlińska M; Ciurzyński M; Pruszczyk P
    Heart; 2012 Aug; 98(16):1221-8. PubMed ID: 22705926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
    Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular filtration rate measured by (99m) Tc-DTPA renal dynamic imaging is significantly lower than that estimated by the CKD-EPI equation in horseshoe kidney patients.
    Qi Y; Hu P; Xie Y; Wei K; Jin M; Ma G; Li Q; Xu B; Chen X
    Nephrology (Carlton); 2016 Jun; 21(6):499-505. PubMed ID: 26517584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Red Blood Cell Distribution Width in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Embolism.
    Wang J; Wan Z; Liu Q; Wang B; Wang L; Yang D; Wang L; Hong Y; Zhu R
    Anal Cell Pathol (Amst); 2020; 2020():1935742. PubMed ID: 32775176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
    Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study.
    Mouronte-Roibás C; Leiro-Fernández V; Ruano-Raviña A; Ramos-Hernández C; Casado-Rey P; Botana-Rial M; García-Rodríguez E; Fernández-Villar A
    Respir Res; 2019 Aug; 20(1):198. PubMed ID: 31455338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.
    Li D; Wu Y; Guo S; Qin J; Feng M; An Y; Zhang J; Li Y; Xiong S; Zhou H; Zeng Q; Chen L; Wen F
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1933-1941. PubMed ID: 31695352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.